Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen replacement therapy for adolescent anorexia nervosa
2022-000696-39Phase 4Active
- Sponsor
- Helse Nord
- Start
- Nov 2022
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of estradiol in anorexia nervosa (AN), sponsored by Helse Nord. Primary endpoints: Anxiety levels and Anorexia nervosa symptom severity. Started Nov 2022; status: active.
02
Drugs
estradiol
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on 2022-000696-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000696-39.